Certara Products - Simcyp Archives | 第 6 页，共 22 页 | Certara

On-Demand Webinar

将 PBPK 模型应用于儿科药物开发的最佳实践框架

Pediatric PBPK models have broad application in the drug development process and are being used…

Certara2021 年 4 月 20 日

White Paper

克服研究障碍：复杂类似药开发的专家指导

Do expensive bioequivalence studies stall your generic drug approval? Learn how you can streamline complex…

Certara2021 年 4 月 15 日

On-Demand Webinar

Predicting the Effect of the Dulaglutide-Mediated Gastric Emptying Delay on Drug Exposure

The European Medicines Agency (EMA) recently approved dulaglutide (Trulicity®) at higher doses (3 mg and…

Certara2021 年 4 月 1 日

Blog

Simcyp Simulator 影响了超过 80 种新药的开发

250 Label claims using PBPK without the need for additional clinical studies “Clinical Studies and…

Certara2021 年 3 月 17 日

Publication

Physiologically- based pharmacokinetic modeling to support bioequivalence and approval of generic products: 双氯芬酸钠局部用凝胶案例，1％

Certara2021 年 3 月 16 日

On-Demand Webinar

IQ WG Evaluation of PBPK Models for Organ-Impaired Populations

• The predictive performance of physiologically based pharmacokinetic(s) (PBPK) models for PK in renal impairment…

Certara2021 年 3 月 10 日

White Paper

应用 Simcyp™ PBPK 技术推进儿科药物研发

Certara2021 年 3 月 4 日

Brochure

Simcyp™ PBPK Simulator

Streamlines drug development by using PBPK modeling to predict drug behavior in virtual populations, optimize…

Certara2021 年 1 月 22 日

Publication

Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and Transporters

Certara2020 年 11 月 13 日

Press Coverage

How PBPK Modeling Can Replace Drug-Drug Interaction Studies

Patients often take more than one drug at a time, especially elderly patients and those…

Certara2020 年 11 月 12 日

© 2025 Certara. 保留所有权力。 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software